Sep 5, 2014 Cellectar Biosciences Announces Participation in Two Upcoming Investor Conferences in September Learn More
Sep 4, 2014 Cellectar Biosciences Announces Acceptance of Investigational New Drug Application to Evaluate I-131-CLR1404 in Clinical Trials in Relapsed or Refractory Multiple Myeloma Learn More
Aug 20, 2014 Cellectar Biosciences Reports Second Quarter 2014 Financial Results and Recent Highlights Learn More
Aug 20, 2014 Cellectar Biosciences Announces Closing of Public Offering and Partial Exercise of Underwriter's Over-Allotment Option Learn More